Oricchio, ElisaWendel, Hans-Guido2022-01-292022-01-292022-01-292021-11-0210.4161/23723548.2014.969640https://infoscience.epfl.ch/handle/20.500.14299/184803WOS:000744289300017Follicular lymphoma (FL) is an incurable form of B-cell lymphoma. Genomic alterations that inactivate RB signaling are surprisingly common in indolent FL. We show that FLs that are positive for phosphorylated RB respond to dual CDK4/BCL2 inhibition. Our results imply that RB phosphorylation identifies patients likely to benefit from such dual intervention.Oncologybcl2cell cyclefollicular lymphomatherapytext::journal::journal article::research article